Piribo: New publication announcement, Pharmaceutical Outsourcing Part 1: Contract Manufacturing Strategies

The dynamics of the contract manufacturing landscape in the pharmaceutical industry are changing. With the increasing globalization of the contract manufacturing market, particularly regarding on-patent biologics and APIs, companies need to position themselves to be able capture the cost savings Asian countries have to offer.

Highlights
While traditionally companies have opted to use contract manufacturing tactically to meet internal shortfalls in capacity or a lack of internal capability, many are overlooking the benefits that strategic contract manufacturing has to offer.The contract manufacturing market is becoming increasingly globalized, with the shift of services from the West to the East. With intellectual property protection and the business environment improving in India and China, these are expected to become popular locations for on-patent biologics and API manufacturing over the next few years.Contract manufacturing agreements often to fail to live up to expectations; however, there are steps that companies can take to minimize the risk of this, such as designing a suitable manufacturing strategy based on your company's requirements and effectively managing the relationship with a vendor.

Scope
- Case-study based evaluation of best practice contract manufacturing strategies used by small and large pharma and biotech companies
- In-depth country profiles examining the suitability of key Asian offshore contract manufacturing locations, including China, India, and Singapore
- Recommendations on how companies can avoid the common pitfalls in contract manufacturing
- Expert opinion from drug manufacturing executives from pharma and biotech companies
Reasons to Purchase
- Identify the best way to tackle the common reasons behind contract manufacturing agreements failing to live up to the customer's expectations
- Assess the commercial implications of the increasing globalization of the API contract manufacturing market
- Understand how to optimize your manufacturing strategies to capture the maximum benefit

Contents
Chapter 1 Overview Of Contract Manufacturing
Chapter 2 Making The Decision To Outsource Manufacturing Functions Or Keep Them In-House
Chapter 3 Process Of Selecting The Right Cmo
Chapter 4 Technology Transfer And Managing The Relationship

“Pharmaceutical Outsourcing Part 1: Contract Manufacturing Strategies - Offshoring is not the only option to drive productivity and efficiencie” is available from Piribo. For more information go to: http://www.piribo.com/publications/production/pharmaceutical_outsourcing_part_1_contract_manufacturing_strategies.html

Piribo Product ID: DAT524

About Piribo.
Piribo (http://www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.